Exos Asset Management’s Expand Energy Corp EXE Stock Holding History

Exos Asset Management’s Portfolio EXE Stock Details EXE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,055	Closed	-$55K	–	723
2021 Q2	$55K	Buy	+1,055	New	+$52.7K	0.03%	543

Other funds holding EXE

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GCM

Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return

Exos Asset Management's EXE Position: Q3 2021 in Review

Exos Asset Management sold out of Expand Energy Corp (EXE) in Q3 2021, closing a stake of 1,055 shares — an estimated $55K sold.

Exos Asset Management first reported a position in EXE in Q2 2021 and held it in 1 quarter. The position peaked at $55K in Q2 2021. 208 funds tracked by Wall St. Rank hold EXE as of Q3 2021.

Exos Asset Management reported no remaining Expand Energy Corp position as of Q3 2021 after selling out during the quarter.
Exos Asset Management sold 1,055 Expand Energy Corp shares in Q3 2021, an estimated $55K.
Exos Asset Management first reported a position in Expand Energy Corp in Q2 2021 and held it in 1 quarter.
Exos Asset Management's Expand Energy Corp position peaked at $55K in Q2 2021.
208 funds tracked by Wall St. Rank held Expand Energy Corp as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.